Cardinal Reaches Deal With FDA Over Drug Pumps
The amended consent decree was submitted to the U.S. District Court for the Southern District of California on Wednesday and requires court approval. It revises an earlier consent decree the company has operated under since 2007 after the FDA found that some of the company's pumps were defective and could cause patients to receive overly high drug doses.
The original decree...
To view the full article, register now.